Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboem‐bolism in the EINSTEIN DVT and EINSTEIN PE Studies

OBJECTIVES: In the EINSTEIN DVT and EINSTEIN PE studies, the majority of patients received heparins to bridge the period during venous thromboembolism (VTE) diagnosis confirmation and the start of the study. In contrast to vitamin K antagonists (VKAs), rivaroxaban may not require initial heparin tre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Acad Emerg Med
Main Authors: Prandoni, Paolo, Prins, Martin H., Cohen, Alexander T., Müller, Katharina, Pap, Ákos F., Tewes, Miriam C., Lensing, Anthonie W. A.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2015
Teme:
Original Contributions
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5024063/
https://ncbi.nlm.nih.gov/pubmed/25676529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acem.12585
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki